Sept 25 (Reuters) – The US Food and Drug Administration has approved AbbVie’s drug for Parkinson’s disease in adults, the health regulator’s website showed on Friday.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar)
Brought to you by www.srnnews.com
SRN News — View the original story at SRNNews.com.
